Hong Fang Song
Director/Board Member at CG ONCOLOGY, INC.
Net worth: 22 M $ as of 30/04/2024
Profile
Hong Fang Song is an Independent Director at CG Oncology, Inc. and a Director at Enable Injections, Inc. She previously worked as a Managing Director at Cowen, Inc. She holds a graduate degree from Claremont Graduate University and an undergraduate degree from Fudan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0.92% | 25/03/2024 | 613,928 ( 0.92% ) | 22 M $ | 30/04/2024 |
Hong Fang Song active positions
| Companies | Position | Start |
|---|---|---|
| CG ONCOLOGY, INC. | Director/Board Member | 01/11/2015 |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Director/Board Member | - |
Former positions of Hong Fang Song
| Companies | Position | End |
|---|---|---|
| COWEN INC. | Corporate Officer/Principal | - |
Training of Hong Fang Song
| Fudan University | Undergraduate Degree |
| Claremont Graduate University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Cowen, Inc. engages in the provision of financial services. It operates through following the segments: Operating Company and Asset Company. The Operating Company segment consists of the Cowen Investment Management, Investment Banking, Markets, and Research divisions. The Asset Company segment consists of the firm’s private investments, private real estate investments, and other legacy investment strategies. The firm offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services, and actively managed alternative investment products. The company was founded in 1918 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Hong Fang Song
